European Archives - Page 1121 of 1166 - European Medical Journal

Cost-Effectiveness of a Novel Self-Apposing Stent in ST-Segment Elevation Myocardial Infarction (STEMI) in France

The objective was to calculate the cost-effectiveness profile of STENTYS compared to conventional bare and drug-eluting stents (DES).

Left Ventricular Cardiomyopathy in Mitral Valve Prolapse: Fact or Fiction?

In most patients with mitral valve prolapse (MVP) without severe mitral regurgitation (MR), left ventricular (LV) function is preserved.

Functional Mitral Regurgitation: If the Myocardium Is Guilty Do We Also Need to ‘Rehabilitate’ the Valve?

Mitral regurgitation (MR) is the most frequent valvulopathy in the general population with an incidence that grows with age and is associated with a poor…

Transcatheter Options for Treatment of Mitral Regurgitation

Transcatheter therapy for valvular heart disease (VHD) as an alternative for surgery, as the standard of care, has emerged rapidly over the last 10 years.

Circulating Haemoglobin Levels and the Risk of Atherosclerosis in Asian Indian Populations

Background: The global burden of coronary heart disease (CHD) is estimated to be the highest on the Indian subcontinent. The pathophysiology of this…

The Program on the Surgical Control of the Hyperlipidemias (POSCH) and the Lipid Regulatory Hypothesis

The Lipid Regulatory Hypothesis (LRH) states that the best way to regress atherosclerotic plaque is to simultaneously decrease the cholesterol being…

How I Treat: Coronary Heart Disease: The Pleiotropic Effects of Statins

Cardiovascular (CV) diseases currently represent the first cause of death in industrialised countries with coronary heart disease (CHD) corresponding to…

EMJ Cardiology 3.1 2015

The field of Cardiology is one which has rapidly evolved over the last few decades; advances in procedures, diagnosis, and treatments have progressively…

EMJ

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells…

EMJ

Combination Therapy Trial for Breast Cancer

BREAST cancer patients with small node-negative HER2-positive tumours achieved 3-year survival approaching 100% with adjuvant paclitaxel and trastuzumab…